New Drug Combination Found Effective Against COVID-19 Infection: Study

Early test results, published in the journal Viruses, found that the combined use of the antiviral drugs nafamostat and Pegasys meets all availability and efficacy requirements.

A new drug combination can suppress infection by the S-CoV-2 virus, which causes COVID-19, according to a study conducted in animals and cell cultures.

Early test results, published in the journal Viruses, found that the combined use of the antiviral drugs nafamostat and Pegasys meets all availability and efficacy requirements.

"This combination effectively suppresses the infection," said Denis Kainov, a professor at the Norwegian University of Science and Technology's (NTNU).

The experiments were performed in cell cultures and hamsters, the researchers said.